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     The morphologically characteristic changes were irregular thickening of the base-
ment membrane in the streptozotocin induced diabetic group (S rats) and more striking 
irregular hypertrophy of the same membrane in the group further administered with 
growth hormone (S+BGH rats). In the outer basement membrane surrounding the pe-
ricytes of S rats and S+BGH rats retinal capillary, and deposit of elastine could be sug-
gested, which were seen as electron lucid, were proved by tannic acid stainning to be 
substances with high electron density. Biochemical assay disclosed that the characteristic 
change was a marked increase in hydroxyproline in the group with diabetes and an in-
crease in hexosamine and also in sialic acid in the group further administrated with 
growth hormone. 
     In view of the above finding, it was considered that substances of the collagen 
group are involved in the thickening of the basement membrane in diabetes, and that 
the loading with growth hormone is influential on glycoproteins deposition.
                   INTRODUCTION 
     It was described in one of our previous papers") that diabetic retinopathy, one of 
the serious complications in diabetes mellitus, was improved by pituitary ablation. How-
ever, there remain not a few aspects yet to be elucidated in the mechanism of the ef-
fect of the surgery, and moreover little is known about the effects of growth hormone on 
the retinal capillaries in diabetes mellitus. For the purpose of elucidating the nature of 
diabetic retinal angiopathy and to reveal the effects of growth hormone, we have re-
cently made morphological and biochemical studies of pathological and biochemical stu-
dies of pathological changes in the retinal blood vessels of rats with the streptozotocin-
induced diabetes, and obtained some interesting findings.
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              MATERIALS AND METHODS 
     Female Wister rats, weighing 180-210 g, were injected intravenously through the 
caudal vein with 65 mg/kg of streptozotocin (The Upjohn Co., U. S. A.) dissolved in 
0.3 ml of a citrate buffer (pH 4.5). 
     One injection was sufficient to induce diabetes. The animals were weighed, and 
their blood sugar levels were measured every 3 weeks after the injection and their urine 
sugar levels every 10 days. A simplified blood sugar measuring equipment "The Ames 
Reflectance Meter" (Ames Co., U. S. A.) (glucose-oxidase method) was used for the 
measurement of blood sugar levels, and the Tes-Tape (Eli Lilly and Co., U. S. A .) 
for the test of urine sugar. The rats with blood sugar levels of not less than 150 mg/ 
dl and with persistent positive urine sugar 10 days after the injection were classified as 
diabetic (S) , and these rats were breeded for the following 6 months. The group 
treated with growth hormone (S+BGH) consisted of the S rats that had been reared for 
six months, then injected intraperitoneally with 3 mg of BGH (Miles Labs. , U. S. A.) 
(activity: 0.8-1.0 U. S. P. units/mg) daily for 10 days, and observed for one month 
prior to their use for experimental purposes. 
1. For the preparation of electron-microscopic speciments, the eyeballs were enucleated 
 from the animals under ether anesthesia while 3 % glutaraldehyde-phosphate buffer 
 (pH 7.3) solution was being applied dropwise ; each eyeball was immediately fixed in 
 the same 3% glutaraldehyde solution for 3 hours ; its retinal tissue was cut into sec-
 tions, fixed in 1% osmium tetraoxide for 2 hours, dehydrated with ethanol, and ern-
 bedded with the Epon 815 resin. Part of the embedded material was stained with 0.1 
     toluidine blue, and, after the presence of small blood vessels in a histochemical
  specimen was confirmed, ultrathin sections were prepared with the Porter-Blum model 
  MT1 ultramicrotome, double stained with uranium acetate and lead citrate, and ex-
 amined under the JEM model 7 electron microscope. Tannic acid staining') was per-
  formed to located that part of the basement membrane which was less electron dense. 
2. For the biochemical study, several units of 30 eyeballs each of the rats breeded by 
 the aforementioned method were assigned to the respective experimental groups. After 
 fixation in 10% formaldehyde solution, the retina was separated and immersed in 3% 
 trypsin solution (by Kuwabara-Cogan's method")) for 8 hours to obtain the retinal 
 blood vessels. The retinal blood vessels thus obtained were homogenized in a Teflon 
 homogenizer, washed and dehydrated with anhydrous acetone, and dried over P205 in 
  a vacuum desiccator, and dry weight was measured. Part of the sample thus prepared
 was assayed for hydroxyproline, hexosamine and sialic acid. 
     1) For the assay of hydroxyproline, part of the dried sample was sealed in a test 
tube together with 1 ml of 6 N hydrochloric acid, and allowed to be hydrolyzed 100°C 
for 16 hours, after the hydrochloric acid was removed, the hydrolysate was made up to 
a given volume with 2 ml of distilled water, and assayed by Neuman-Logan's method 
15)
     2) For the assay of hexosamine, part of the dried sample was added with 1 ml 
of 6 N hydrochloric acid. The mixture was sealed in a test tube and hydrolyzed at 100 
°C for 6 hours . After removal of the hydrochloric acid, the hydrolysate was made up 
to a given volume with 2 ml of distilled water, and assayed for hexosamine by Rondle-
Morgan's method17>. 
     3) For the assay of sialic acid, part of the dried sample was digested with pa-
pain at 65° for 1 hour. The digest was added to 1 ml of 0.1 N sulfuric acid, and hy-
drolyzed at 80°C for 1 hour. The hydrolysate was centrifuged and the supernatant was 
assayed for slialic acid by the thiobarbituric acid method18). 
                     RESULTS 
1 Biological behavior of rats 
     1) Body weights and blood sugar levels of BGH-treated rats 
        While normal rats weighed 192±16 g (mean±S. D.) and had the blood sugar 
  levels of 89±9 mg/dl, the animals one month after daily treatment with 3 mg of BGH 
 for 10 days weighed 230±11 g and had the blood sugar levels of 114±13 mg/dl. 
 Thus, the latter presented increased body weights and increased blood sugar levels, 
 though the urine sugar remained negative. These findings proved BGH to be diabe-
  togenic. 
     2) Body weights and blood sugar levels of S-rats. 
         The S-rats that had been reared for 6 months prior to BGH administration 
 weighed 207±31.5 g and had the blood sugar levels of 531±39.6 mg/dl. 
     3) Body weights and blood sugar levels of S+BGH rats. 
        The above-mentioned S rats were administered daily with 3 mg of BGH for 
  10 days ; and their body weights and blood sugar levels were measured, 15 days and 
  30 days after the end of the administrations. The animals weighed 227±17 g, and 
  had the blood sugar levels of 452±26 mg/dl at termination of the administration, 246 
  ±17 g and 527±46 mg/dl 15 days after the administrations, and 259±24 g and 32 mg/ 
  dl 30 days after the administrations. 
         The maximum blood pressure measured with the automatic blood pressure re-
  corder model USM-105 (Ueda Electronic Works) at the end of each experiment was 
  102±14 mmHg remaining within normal range. 
2. Electron-microscopical findings (Figs. 1-5) 
    Electron-microscopical observation was made for retinal capillaries of which the ba-
  sement membrane surrounding the endothelium was in direct contact at least in part 
  with the surrounding glia tissue. The capillary plexuses of the retina in the posterior 
  pole were divided into 2 layers ; the plexuses in the nerve fiber layer and the ganglion 
  cell layer were defined as the superficial layer ones, and those in the inner nuclear 
  layer to the outer plexiform layer as the deep layer ones.
    1) Retinal capillaries of normal rats (Fig. 1) 
       There was no morphologic difference between the superficial and deep layer 
capillaries. The retinal capillary lumen consisted of a thin monolaminar endothelium 
without fenestration. The endothelial cells were tightly interconnected. Their nuclei 
were shaped irregularly and their cytoplasm contained a few mitochondria and poly-
somes and a relatively large number of pinocytotic vesicles in contact with the surface 
of the internal cavity. The outer basement membrane contacting the pericytes was 
500-2500 A thick, and the inner basement membrane contacting the endothelium 500-
2000 A thick. It consisted of amorphous substances with mostly consistent electron 
density (Fig. 1). 
   2) Retinal capillaries of S rats (Fig. 2) 
       Localized irregular thickening of the basement membrane was remarkable so as 
to measure 700-7500 A in both the inner and outer basement membranes. Electron-
lucid, almost homogeneous substances were present in the thickened basement mem-
brane. The pericytes showed a decrease of cytoplasmic organelles associated with a 
marked decrease in electron density. 
       Changes in the endothelial cells were far less than those in the basement mem-
brane and pericytes, but pinocytotic vesicles were increased. 
   3) Retinal capillaries of S+BGH rats (Fig. 3-5) 
       The basement membrane of deep capillaries was irregularly and prominently 
thickened in some localities, being even as thick as 8000 A at some sites.
Fig. 1 Cross section of retinal capillary of normal rat (x 6800)
Fig. 2 Cross section of retinal capillary of S rat, shows an irregular thickening of the 
      basement lamina (x 5800)
Fig. 3 Cross section of retinal capillary of S+BGH rat deposit of low electron density 
      substance in outer basement lamia (x 10000)
Fig. 4 High magnification of Fig. 3 (x 47000)
Fig. 5 Cross section of retinal capillary of S+BGH rat the electron lucid meterials was 
      showed as high electron density substances by tannic-acid staining (x 12000)
         In the outer basement membrane surrounding the pericytes of the deep capil-
  laries, there were some parts which were as electron-lucid as those found in the reti-
 nal capillaries of S rats, and which were proved by tannic acid stainning to be sub-
 stances with high electron density (Fig. 3, 4 and 5, 6). 
3. Biochemical analysis of retinal blood vessels 
   For the biochemical study, 30 eyeballs each from normal rats, S rats and S+BGH 
 rats collected as a unit were preserved in 10% formaldehyde solution ; after washing 
 the eyeballs, the retinas were separated and the retinal blood vessels were isolated by 
 Kuwabara-Cogan's trypsin digesting method (8 hours) for use as materials. In order to 
 know the degrees of damages to the blood vessels, preliminary experiments were 
 made by electron-microscopic observation of the retinal blood vessels after the diges-
 tion. Further several units of 30 normal retinas were assayed at different times for 
 hydroxyproline, hexosamine, and sialic acid to confirm their contents to be mostly con-
 stant. 
        The results of assays of 30 retinas each from the three groups after 8-hour 
 digestion were as shown in Table 1.
Table 1. Hydroxyproline, Hexosamine and Sialic acid content of normal, S and 
        S+BGH rats retinal vascular system
                   Hydroxyproline Hexosamine Sialic Acid 
Normal rats 10.40±0.31 12.38±0.43 10.26±0.31 
S rats 18.90±1.20 21.60±1.20 18.90±1.12 
S+BGH rats 19.10±0.64 27.60±0.75 23.40±0.70 
               mg/g dry weight tissue ± S.E.
                    DISCUSSION 
     Ever since streptozotocin, a broad spectrum antibiotic produced from Streptomyces 
achromogenes, was reported by Rakieten19) in 1963 to be diabetogenic, this compound 
has been frequently used in animal experiments. 
     A single administration of streptozotocin is considered to induce diabetes with very 
high frequency, and selectively destroy the (3 cells of the islands of Langerhans. On 
the other hand, it has been proved that growth hormone is greatly influential on sugar 
metabolism, its major actions being (1) hypoglycemic action, (2) sugar transport and 
glycolysis, (3) glycogen retaining action, and (4) diabetogenic action. 
     The relationship between diabetic retinopathy and growth hormone administration 
was described for the first time by POULSEN16' in 1936, and LUFT et al"). in 1955 
demonstrated that pituitary ablation is effective in treatment of the retinopathy. Many 
reports have been published on this theme ever since.
       There are reports by LEUEMBERGER et a112)13). SOSULA et a121) . KOJIMA et a110) 
 TANIGUCHI et a123'. WATANABE24) , and BABEL et al"). on electron-microscopic 
 studies of the retinal capillaries in experimental diabetes. LEUEMBERGER et a112>13> 
 showed the diposition of a basement membrane-like substance in the retinal capillary 
 basement membrane and fibrous substance-containing thickening of the membrane of S 
 rats that had been breeded for not less than 6 months; and BABEL et al3). also, 
 observed irregular thickening of the basemrent membrane of S rats that had been breeded 
 for 6-12 months. 
      TANIGUCHI et al23>. obtained a finding similar to vacuolation within the base-
 ment membrane. However, the electron lucid part in the middle of the basement mem-
 brane found in our present study was not surrounded by the limiting membrane, and 
thus it could not be considered as vacuolation. 
      Studies on experimental diabetic retinopathy with growth hormone were made by 
HAUSLER s> in 1936, by ENGERMAN 5) in 1965, by AGARWALI) in 1965, and by 
BLOODWORTH 4> in 1969. In our electron microscopy of the retinal capillaries of 
BGH-treated rats, however, capillary hemorrhage, microaneurysm, acellularity, and dis-
appearance of mural cells which had been described by the aforementioned authors 
were not found. 
      Thus BGH appeared to play little or no role as a retinopathyinducing factor. 
Therefore, from the point of view that it might be a retinopathy-accelerating factor, 
the retinal blood vessels of rats treated with STZ+BGH were studied. 
      There are few literature on the administration of growth hormone to animals in 
experimental diabetic condition nor are there any published data from biochemical stu-
dies. The electron lucid parts similar to those noted in STZ-treated rats were also ob-
served in part of the basement membrane of deep capillaries, especially in the outer 
membrane surrounding pericytes. This finding is what is commonly called vacuole ca-
vitation or "Swiss cheese." ASHTON21) in 1974 described it as lipid inclusion. How-
ever, we morphologically consider it as representing the presence of elastin, for the 
reasons (1) that the central area was electron lucid, (2) that the central area was sur-
rounded by substances with high electron density, (3) that such structures occurred 
within the basement membrane, and (4) that the electron-lucid areas stained with tan-
nic acid. 
     There are two ways of thinking about the mechanism of thickening of the base-
ment membrane, i.e., lack of native enzyme') and a acceleration of mucopolysaccharide 
composition ability20). However, there appears to be no objection to the concept that the 
thickening is caused by the deposition of mucopolysaccharides in the basement membrane . 
     In the endothelial cells increased transport activity was observed.. Such morpho-
logic changes were more frequent in the deep capillaries than in the superficial ones , 
and this finding was consistent with the opinion that changes in. the blood capillaries 
due to diabetic retinopathy are severe in the area close to the inner granular layers). 
There were, however, no appearent morphologic differences , from the rats treated with
STZ. 
     Few biochemical studies have been made of diabetic retinal angiopathy. As the 
results of this study in which the retinal blood vessels were separated by trypsin diges-
tion from the retina of normal men and diabetics, and assayed for hydroxyproline, he-
xosamine and sialic acid, HEATH7) in 1967 described that hydroxyproline was most in-
creased in the diabetic eyeballs, followed by the increase in hexosamine, while sialic 
acid was not increased on the whole. Biochemical changes in the glomeruli in diabetic 
nephiopathy are already known to a considerable extent. Based on the concept that pa-
thologic changes in the glomerular basement membrane arise from abnormal sugar and 
protein metabolisms, SPIRO20) showed that the increase in glycorylgalactosyl-hydroxylysine 
in the basement membrane due to insulin shortage is the one and only characteristic 
change. 
      Alterations in the assays that were noted in the 3 groups, i.e. , the group o f 
normal rats, the group of rats treated with STZ and the group treated with STZ+BGH 
were considered to have resulted from the diabetic conditions in the respective groups 
and also from the direct or indirect effects of BGH. 
     Hyproxyproline, a characteristic amino acid of fiber protein, was strikingly in-
creased in diabetes, and the administration of growth hormone markedly increased he-
xosamine and sialic acid which represent mucopolysaccharides or sial glycoproteins.
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